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Abstract: Ample evidence exists showing that eukaryotic signal molecules synthesized 
and released by the host can activate the virulence of opportunistic pathogens. The 
sensitivity of prokaryotes to host signal molecules requires the presence of bacterial 
sensors. These prokaryotic sensors, or receptors, have a double function: stereospecific 
recognition in a complex environment and transduction of the message in order to initiate 
bacterial physiological modifications. As messengers are generally unable to freely cross 
the bacterial membrane, they require either the presence of sensors anchored in the 
membrane or transporters allowing direct recognition inside the bacterial cytoplasm. Since 
the discovery of quorum sensing, it was established that the production of virulence factors 
by bacteria is tightly growth-phase regulated. It is now obvious that expression of bacterial 
virulence is also controlled by detection of the eukaryotic messengers released in the 
micro-environment as endocrine or neuro-endocrine modulators. In the presence of host 
physiological stress many eukaryotic factors are released and detected by Gram-negative 
bacteria which in return rapidly adapt their physiology. For instance, Pseudomonas 
aeruginosa  can bind elements of the host immune system such as interferon-γ and 
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dynorphin and then through quorum sensing circuitry enhance its virulence. Escherichia 
coli sensitivity to the neurohormones of the catecholamines family appears relayed by a 
recently identified bacterial adrenergic receptor. In the present review, we will describe the 
mechanisms by which various eukaryotic signal molecules produced by host may activate 
Gram-negative bacteria virulence. Particular attention will be paid to Pseudomonas, a 
genus whose representative species, P. aeruginosa, is a common opportunistic pathogen. 
The discussion will be particularly focused on the pivotal role played by these new types of 
pathogen sensors from the sensing to the transduction mechanism involved in virulence 
factors regulation. Finally, we will discuss the consequence of the impact of host signal 
molecules on commensally or opportunistic pathogens associated with different   
human tissue. 
Keywords:  pathogens; sensors; pseudomonas; neurotransmitters; cytokines; hormones; 
host-pathogen interactions; virulence 
 
1. Introduction  
The number of microorganisms that live inside or on the body of a healthy human adult is estimated 
at least 10 times greater than the number of human somatic and germ cells [1]. By the end of 2007, the 
study of this important community was at the origin of the Human Microbiome Project, with the goal 
of identifying and characterizing all microorganisms found in association with both healthy and 
diseased humans [2]. The composition of this bacterial community is the result of the combined effects 
of a selection pressure due to the competition between microbial species, to bacterial strategies of 
adaptation to the host but also of the host response itself [3-5]. It is then obvious that communication is 
the key factor regulating this complex ecological system. Besides quorum sensing factors exchanged 
between bacterial strains or species, bacteria produce virulence factors against the host. Meanwhile, 
defensins or cytokines are produced by the host in response to the microbial attack, even in the cases 
where bacteria and eukaryotic cells evolve in perfect harmony. Consequently the two cell types are 
continuously exposed to signals that can be sensed by both partners.  
The ability of a bacterium to persist on or in its host requires that it develops a strategy of tolerance 
to remain non detectable. Bacteria can modify the host membrane to remain adherent but not engulfed 
in lysosome [6], or modify the cytoskeleton of the host cell in a way that promotes their own   
uptake [7], or even exploit innate immune receptors to penetrate into the host cell where they are 
protected from destruction [8]. Host defense against bacteria depends on innate or acquired immune 
recognition of the micro-organisms through pattern recognition receptors targeted towards surface 
(lipopolysaccharides – LPS, peptidoglycans, flagellin, porins, etc.) or inner (DNA, enzymes, toxins, etc.) 
determinants [9]. In most cells, identification of the bacterial molecules is achieved through membrane 
toll-like receptors (TLRs) and cytosolic nucleotide oligomerization domain   
proteins (NOD) [9,10]. Subtype 4 Toll-like receptors (TLR4) that bind to LPS, the endotoxin of   
Gram-negative bacteria, represent the principal sensing pathway involved in the detection of these 
micro-organisms. Stimulation of TLR4 initiates the production of pro-inflammatory cytokines and Sensors 2009, 9                  
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chemokines that recruit and activate leukocytes [11,12] which then activates the whole inflammatory 
cascade in response to bacterial pathogens [13]. Interestingly, LPS is not an invariant structure. A 
unique bacterium expresses multiple forms of LPS that can be rapidly modified in response to 
environmental pressures [14]. For example, Salmonella deacylates and palmitoylates lipid A in 
response to the host micro-environment, which allow this bacterium to avoid detection through   
TLR4 [15]. Similarly, Yersinia and Pseudomonas species also modulate their LPS structures, resulting 
in diminished TLR4 responses to infection [16,17]. These findings have demonstrated that bacteria can 
rapidly modulate their surface determinants or the host recognition patterns and then control both 
constituents of the sensing system. 
During the establishment of the infectious process, bacteria are exposed and can detect eukaryotic 
products. A number of pathogenic bacteria have receptors for plasma proteins [18,19] and for different 
extracellular matrix proteins [20-22]. Bacterial binding to collagen, fibronectin, and laminin has been 
proposed as an important mechanism for bacterial adherence to target tissues [22,23]. This binding is 
often, if not systematically, associated to metabolic changes of the micro-organism. The principal 
mechanism by which bacteria detect and respond to variations of environmental conditions is the two-
component signal transduction system [24,25] but other sensory mechanisms are also expressed by 
bacteria [26-29]. Indeed, bioinformatic studies have made it possible to identify in the genome of 
prokaryotes sequences showing homology with all great families of eukaryotic receptors (i.e. kinase 
receptor, seven transmembrane receptor, ion channel receptors, etc.) [26,28-32], suggesting that 
bacteria could express sensors for a multitude of eukaryotic signal molecules including cytokines, 
neurotransmitters and hormones. 
Among these eukaryotic signal molecules, it was recently demonstrated that bacteria express 
adrenergic-like receptors/sensors able to recognize specifically host epinephrine and nor-epinephrine [33]. 
This discovery is the accomplishment of works started in the beginning of the 1990s, showing that 
bacteria are sensitive to stress-related neuroendocrine hormones produced by the host [34,35]. The 
study of the mechanisms by which stress influences the pathogenesis of infectious disease has allowed 
the emergence of a new transdisciplinary discipline named microbial endocrinology [36-38]. 
Since Lyte and Ernst’s precursor work, the bacterial sensitivity to eukaryotic signal molecules 
appears much wider than initially suspected. In addition to the stress neurohormones [34,39], 
immunomodulatory peptides are sensed by bacteria [40,41]. Infectious agents are also influenced by 
other classical eukaryotic hormones as insulin [42], somatostatin [43] or natriuretic peptides [44]. 
However, pathogens not only express sensors for host molecules but also use these sensors to increase 
the probability of success of their infectious program.  
The neurohumoral environment of the host being an unexpected regulatory network controlling 
bacterial virulence, microbial endocrinology is now an essential domain of investigation to understand 
the precise mechanisms at the centre of the pathogenic process. In this review we attempted to analyse 
the more recent data concerning the physiological effects of eukaryotic signal molecules on Gram-
negative bacteria, the nature of these bacterial sensors involved in recognition and their implication in 
the regulation of virulence.  
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2. Discussion  
2.1. Gram-negative Bacteria and Neurotransmitters 
Stress-related neuroendocrine hormones and more specifically catecholamines have been suspected 
for a long time to interact with prokaryotes. Indeed, as early as 1930, almost immediately following its 
first use as therapeutics, cases of adrenaline-associated sepsis were reported [45]. From this time   
to 1992, the most widely accepted theory to explain the ability of hormones to influence the course of 
infection involves the suppression of the immune system [36]. The hypothesis that the infectious 
microorganism itself might be responsive to the host's neuroendocrine environment appeared in 1992, 
by using a serum-based medium to demonstrate that exposure to catecholamines induced log-fold 
increases in growth of a limited number of Gram-negative pathogens [34]. This date marked the 
emergence of an interdisciplinary field, in frontiers of both neuroendocrinology and microbiology and 
then named microbial endocrinology [36,46].  
The examination of a much larger set of clinical isolates by Freestone et al. showed that recognition 
of catecholamines was widespread amongst Gram-positive and Gram-negative bacteria [47]. The 
ability of norepinephrine, epinephrine and dopamine to enhance the growth of Escherichia coli, 
Yersinia enterocolitica and Pseudomonas aeruginosa was observed to be dependent on the bacterium 
species or strain showing marked preference for one or more of the catecholamines [34]. However, 
norepinephrine was consistently observed to possess the greatest increase in bacterial growth for all 
strains tested. 
Subsequent reports have extended the range of stress hormone-responsive bacteria [48], as well as 
demonstrated further roles for catecholamines in the production of virulence-associated factors such as 
toxins [49] and adhesins [50], biofilm formation [51], and quorum sensing [52]. The ability of 
catecholamines and related inotropes, more precisely norepinephrine, dopamine, and dobutamine (an 
analogue of dopamine), to increase both bacterial growth and production of virulence associated 
factors has been demonstrated in a large series of Gram-negative bacteria (Table 1) [47-49,53-55].  
The principal mechanism proposed initially to explain the effects of catecholamines was due to the 
fact that these molecules can bind iron and can be recognized by bacteria as accessory siderophores 
(iron transporters) [56,57]. However, recently published works [58,59] suggest that the mechanism by 
which catecholamines act on bacteria is certainly much more complex. The question of a direct 
receptor-mediated recognition of catecholamine by bacteria as a communication signal is still 
controversial. It was first reported that neither α- nor β-adrenergic receptor agonists or antagonists can 
affect bacterial growth as observed with norepinephrine [35], suggesting the absence of adrenergic 
receptor-like mediated system. However a recent report using a wide spectrum of adrenergic and 
dopaminergic antagonists confirmed the presence of specific recognition systems for norepinephrine, 
epinephrine and dopamine [58].  
During study of the activator of the quorum-sensing E. coli regulator A (QseA), QseC/QseB, a two-
component regulatory system, was identified [60,61]. Interestingly, the activators of this regulatory 
system, which represent a type of sensor, can be from prokaryotic origin (quorum sensing signal 
autoinducer AI3) but also from eukaryotic origin (epinephrine/norepinephrine) [33,52,62]. Binding and Sensors 2009, 9                  
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pharmacological studies suggest now that the QseC sensor kinase represents a bacterial analog of a 
eukaryotic adrenergic receptor [33,52,63].  
 
Table 1. Neurotransmitters and bacteria. 
Signal molecules  Bacterial species  Observed effect  References 
  Acinetobacter lwoffii  ↑Growth [47] 
  Bordetella bronchiseptica  ↑Growth [48] 
  Campylobacter jejuni  ↑Growth, virulence  [154] 
  Citrobacter freundii  ↑Growth [47] 
  Hafnia alvei  ↑Growth [47] 
Norepinephrine  Morganella morganii  ↑Growth [47] 
 
 
Proteus mirabilis 
Shigella sonnei 
↑Growth 
↑Growth 
[47] 
[55] 
 
 
 
Vibrio splendidus 
Vibrio parahaemolyticus 
Xanthomonas maltophilia 
↑Growth 
↑Growth, virulence 
↑Growth 
[155] 
[156, 157] 
[47] 
 
 
Catecholamines 
Escherichia coli 
Aeromonas hydrophila 
Pseudomonas aeruginosa 
Salmonella enterica 
Yersinia enterocolitica 
↑Growth 
↑Growth 
↑Growth, virulence 
↑Growth, adhesion 
↑Growth 
[34, 58] 
[54] 
[47, 55, 68, 69] 
[59] 
[34, 59] 
 
GABA 
Agrobacterium tumefaciens  ↑Virulence [85] 
  Pseudomonas aeruginosa  ↑Virulence [87] 
This Table summarizes the different neurotransmitters that were shown to modify directly Gram-
negative bacteria physiology, the neurotransmitter-responsive bacteria and the observed effects. 
GABA: gamma aminobutyric acid. 
 
The QseC/QseB system belongs to the family of the bacterial two-component systems. QseC senses 
the epinephrine or the norepinephrine and phosphorylates its associated transcription factor QseB, 
which finally regulates expression of bacterial virulence genes [33,64]. More detailed molecular 
analysis of the QseC signaling mechanism has shown that this sensor activates the expression of 
another two component signal system named QseE/QseF [64]. This new system should represent a 
second bacterial adrenergic receptor subfamily specifically activated by epinephrine but not by AI-3 [65]. 
It appears that, as in mammals, different sensors for a same eukaryotic molecule can co-exist in a 
bacterium and should be coupled to different bacterial physiological responses. Bioinformatic 
screening of E. coli QseE analogs have made it possible to identify the presence of proteins related to 
this sensor in 25 important human and plant bacterial pathogens [64], including Shigella flexneri [64], 
Salmonella enterica Typhimurium [66,67] and P. aeruginosa [64]. In vivo studies showing that qseC 
mutants have lower virulence in rabbits (E. coli mutants) and in pigs (S. enterica mutants) [33,66], 
confirm the probable involvement of bacterial adrenergic sensor(s) in the global virulence of   
many pathogens. Sensors 2009, 9                  
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In P. aeruginosa norepinephrine enhances growth through a reduction of the lag time [47,55]. 
Norepinephrine and dopamine are more effective than epinephrine and isoproterenol (β1- and   
β2-adrenoreceptor agonists) [68] but the detection pathway was not studied in detail. It was only 
shown that, in P. aeruginosa, norepinephrine increases the expression of the PA-I lectin by the 
bacterium [69]. This complex plays a key role in the pathogenicity of P. aeruginosa in the intestinal 
epithelium [70]. In addition, P. aeruginosa express a two-component regulator system signal sensor 
kinase called PmrB that shows significant homology with the E. coli catecholamine sensor QseC [64]. 
As P. aeruginosa is a minor intestinal commensal [71] and that surgical stress increases intestinal 
norepinephrine release [69] changes in the micro-environment of the bacterium could result in 
unexpected variations of virulence. Gamma aminobutyric acid (GABA) represents the most important 
inhibitory neurotransmitter in animals [72]. In micro-organisms, GABA has been during a long time, 
considered only as a nutriment [73,74]. However, the presence in bacteria of enzymes implicated in the 
GABA metabolism allows the synthesis of this neurotransmitter by prokaryotes [75,76]. It was even 
shown that bacteria are able to release GABA [77,78], suggesting that, as in eukaryotes, GABA should 
represent a communication molecule. The physiological relevance of GABA-release by bacteria was 
demonstrated by showing that GABA from diverse micro-organisms rapidly and synchronously induce 
planktonic larvae of the red abalone, Haliotis rufescens, to settle and commence behavioral and 
developmental metamorphosis [78-80]. 
The molecular mechanism involved in bacterial uptake of GABA has been characterized and a 
possible direct action of GABA on micro-organisms has been evaluated. The presence of a bacterial 
GABA binding protein (GBP) was first demonstrated in Pseudomonas fluorescens [81]. The GBP was 
partially purified and was identified as a 42 kDa periplasmic protein [82]. This bacterial GBP shows 
high affinity and specificity for GABA, additionally it is saturable, sodium-independent and 
competitively inhibited by muscimol (a potent GABA analogue) [81]. This GBP therefore shares 
common characteristics with the mammalian GABAA-receptor for GABA [83] strongly suggesting that 
GABA should be considered as a bacterial communication molecule. The bacterial GBP appears to be 
present in other micro-organisms, such as the plant pathogen Agrobacterium tumefaciens, in which this 
GABA sensor was even recently cloned, purified and crystallized [84]. In A. tumefaciens, GABA 
produced by plants after injury, modifies the production of the bacterial quorum sensing molecule, 
which thereby modulates A. tumefaciens virulence [85]. This result provides evidence for the inter-
kingdom communication function of GABA between eukaryotes and bacteria. The study of the direct 
impact of GABA on bacteria has shown that this neurotransmitter influences transcriptional activities 
in Pseudomonas aeruginosa [86], suggesting that animal or human pathogens such as P. aeruginosa 
are also sensitive to GABA. This hypothesis was confirmed by the observation that exogenous GABA 
modulates the global virulence profile of both P. aeruginosa and P. fluorescens toward animal cells in 
vitro [87]. 
2.2. Gram-negative Bacteria and Immune System Communication Molecules 
Cytokines are polypeptide signal molecules mediating a multitude of physiological responses to 
infection and particularly inflammation. Their actions are relayed by a cascade of biological events 
leading to propagation of inflammatory response and host defense against pathogens. The natural role Sensors 2009, 9                  
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of these molecules, when they are present at the right concentration, is positive for the host since they 
recruit and activate immune cells so as to eradicate the germs at the origin of the infectious process. In 
addition to this well documented role of cytokines, another parallel action during the infectious process 
was suspected at the beginning of the 1990s. Indeed, it was shown that stress can promote massive 
translocation of intestinal bacteria and/or toxins into the systemic compartment [88]. This mechanism 
provokes the release of pro-inflammatory cytokines and other signaling molecules which participate in 
the systemic inflammatory response syndrome. Bacteria then come in to direct contact with these 
eukaryotic molecules. These observations were at the origin of the study of the effect of cytokines  
on bacteria. 
The direct impact of cytokines on bacteria was strongly investigated in vitro (Table 2) and was led 
to the observation that, interleukin-1 [40], interleukin-2 [89], granulocyte-macrophage colony-stimulating 
factor [89], interleukin-6 [90], interferon-γ [41] and tumor necrosis factor α [91] all promote bacterial 
growth. Only, IL-4 was without effect on bacterial growth [89]. It does appear that cytokines have a 
dual effect on inflammation and infection; pro-inflammatory cytokines act as stimulators of bacterial 
growth when they reach a sufficient concentration [92]. 
 
Table 2. Immune modulators and bacteria. 
Signal molecules  Bacterial species  Observed effect  References 
 
IL-1β 
Escherichia coli  ↑Growth [40] 
  Acinetobacter spp  ↑Growth [90] 
TNF-α  Shigella flexneri  ↑Invasion [91] 
IL-2  Escherichia coli  ↑Growth [89] 
GM-CSF  Escherichia coli  ↑Growth [89] 
IL-6  Pseudomonas aeruginosa  ↑Growth [90] 
 
 
INF-γ 
 
Klebsiella pneumoniae 
Escherichia coli 
Pseudomonas aeruginosa 
↑Growth 
↑Growth 
↑QS/virulence 
[41] 
[41] 
[96] 
Dynorphin  Pseudomonas aeruginosa  ↑QS/virulence [99] 
This Table summarizes the different immune modulators that were shown to modify 
directly Gram-negative bacteria physiology, the immune modulator-responsive bacteria and 
the observed effects. QS: Quorum sensing, GM-CSF: Granulocyte Macrophage Colony 
Stimulating Factor. 
 
The effect of cytokines involves the presence of membrane structures at the surface of bacteria to 
allow detection of these polypeptide eukaryotic molecules. This hypothesis was essentially 
investigated by binding experiments using radiolabeled ligands. It was shown that interleukin-1 β (IL-1 β) 
binds to virulent Escherichia coli strains in a saturable way [40]. The fact that IL-1ra, a specific IL-1 
receptor antagonist, inhibited the binding of IL-1 β was consistent with the presence of a functional IL-
1-like receptor structure on this bacterial strain [40]. The search for the bacterial sensor of IL-1 β led to 
the identification of Caf1A (capsule antigen F1 assembly) a protein from Yersinia pestis which is the 
target of IL-1 β in this species [93]. The high specificity and affinity of IL-1 β to Caf1A (Kd = 1.40 × 10
-10 M) Sensors 2009, 9                  
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enabled this protein to be designated as a real IL-1 β bacterial receptor [93]. The localization of Caf1A 
in the outer membrane of the bacterium is in harmony with a role of sensor. Caf1 A is then 
characterized by a double function, the first identified in capsule antigen F1 assembly and the second 
in the detection of IL-1β. The transduction mechanism which allows for the passage of the signal 
detected in the outer bacterial membrane to induction of bacterial growth remains to be investigated. 
Additionally Caf1 A is the unique bacterial sensor for human IL-1β identified until now. Furthermore, 
while it was also suggested that the IL-1 β bacterial sensor should be involved in the regulation of 
bacterial pathogenicity [40] this activity was never directly demonstrated. 
Another cytokine, TNF-α, can also bind to a great diversity of Gram-negative bacteria [91]. The 
sensor for TNF-α was investigated in detail in the bacterial pathogen Shigella flexneri. This receptor is 
expressed at an average of 276 copies per bacterium and its Kd measured using 
125I-labeled TNF-α is 
about 2.5 nM [91]. The pharmacological properties of the bacterial TNF-α receptor are clearly 
different from its eukaryotic counterpart [94]. For instance, the binding of labeled TNF-α to the 
bacterial receptor can be inhibited by cold TNF-α but not by cold TNF-β. Moreover monoclonal 
antibodies to the 55-kDa or 75-kDa TNF-α receptor, the major forms expressed in eukaryotic cells, 
have no effect on 
125I-TNF-α binding to bacteria [91]. As observed with interleukins, TNF-α appears to 
promote bacterial virulence even though it does not act on bacterial growth. Indeed, pre-treatment of S. 
flexneri with TNF-α increases the invasive potential of the bacteria on HeLa cells [91]. It is interesting 
to note that this phenomenon is abrogated when HeLa cells are exposed to antibodies against the 55-kDa 
TNF-α receptor subtype suggesting that TNF-α/TNF-α bacterial receptor complexes should interact 
with eukaryotic TNF-α receptors. Whereas host cells are known to express receptors recognizing 
bacteria for the purpose of activating the immune system, this work reveals that bacteria themselves 
might possess specialized receptors that in turn recognize and respond to host immune activation.  
Such bacterial sensors should explain the behavior of opportunistic pathogens that only express 
virulence in organisms having abnormal immunological or inflammatory status. This is the case of P. 
aeruginosa that
 can colonize various environmental niches and is only able to infect hosts with 
defective immune system function [95]. None of the cytokines tested, including human IL-2, IL-4, IL-6, 
IL-8, IL-10, IL-12, interferon gamma (IFN-γ), and tumor necrosis factor alpha (TNF-α) have any 
significant effect on growth of P. aeruginosa [96]. However, screening of the impact of cytokines on 
the secretion of virulence factors by this bacterium, revealed that the expression of type I lectin (PA-I 
lectin), an adhesin essential to the lethality of P. aeruginosa [70], and production of the siderophore 
pyocyanin, are specifically induced by IFN-γ [96]. Concurrently it was demonstrated that the effect of 
IFN-γ on P. aeruginosa is associated with the activation of inter-bacterial Quorum sensing 
communication [96]. A 35-kD protein was found in the outer membrane of P. aeruginosa that binds 
specifically this cytokine in a dose dependent manner [96]. This protein was identified by 
electronspray ionization / telomeric repeat amplification liquid chromatography tandem mass 
spectrometry as the outer membrane porin OprF [96]. This result was confirmed by construction of 
OprF deletion mutants.  
Toxicological studies were at the origin of observations that lead to identification of another family 
of mediators of inflammation specifically detected by bacteria. There is ample evidence that the 
prevalence and severity of bacterial infections is increased in injected opiate users [97]. In addition, it 
is known that following stress, endogenous opioids act as paracrine and autocrine signals with high Sensors 2009, 9                  
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levels of functional redundancy and pleiotropy [98]. These observations, coupled with the findings that 
neutrophils themselves can synthesize and release opioids at the inflammation site, strongly suggest 
that bacteria are exposed to opioids during the course of infection. Experimental studies showed that in 
mice, stress results in the release of factors, including opioids, into the intestinal lumen which directly 
activate the virulence of P. aeruginosa, leading to disruption in the intestinal epithelial barrier [96]. In 
order to explain this phenomenon, Alverdy’s group tested the impact of different opioids, with 
specificity towards µ-, λ- and κ-opioid receptors, on the growth of P. aeruginosa PAO1. None of the 
opioids agonists were active on bacterial growth in PAO1 but it appeared that the synthetic agonist U-50,488 
and dynorphin, an endogenous κ-opioid receptor ligand enhanced the virulence of the bacterium [99]. 
This effect was attributed to an increase of bacterial pyocyanin production [99]. This result is another 
demonstration that eukaryotic signal molecules can modify the physiology of bacteria without directly 
affecting their growth rate. The original action of ligands of κ-opioid receptors on P. aeruginosa 
strongly supported the hypothesis that these micro-organisms expressed a specific sensor for opioid-
related molecules [99]. The physiological relevance of this hypothesis was studied by an in vivo 
experiment, showing that dynorphin is released into the intestinal lumen after injury and accumulates 
on desquamated epithelium, where it finally binds to P. aeruginosa [99]. The binding of dynorphin  
to P. aeruginosa was confirmed in vitro by direct immunostaining using anti-dynorphin antibodies. 
More precisely, electron microscopic studies revealed that dynorphin was found predominantly in the 
cytosolic compartment of bacterial cells [99] suggesting that, despite its peptide structure, dynorphin 
was able to cross the double membrane of P. aeruginosa. This unexpected phenomenon requires that 
dynorphin either binds a membrane sensor which is then translocated into the bacterial stroma or that 
dynorphin can cross the membranes through porins or transporters before being recognized by a 
cytoplasmic sensor. The second hypothesis appears more probable, since in eukaryotic cells dynorphin 
can cross the cytoplasmic membrane through a mechanism which is independent of opioid   
receptors [100]. Afterwards, dynorphin could act the same way on intra-bacterial opioid receptor-like 
molecules. Until now the cytoplasmic target of dynorphin in bacteria was not been identified. It was 
demonstrated that in P. aeruginosa, the global virulence regulator Mvfr [101] is involved in the action 
of dynorphin [99] but it does not appear as the real binding site of dynorphin. 
Finally, we can also notice that whereas eukaryotic immune communication molecules can interfere 
with bacterial virulence by acting on the production of bacterial communication molecules of the 
quorum sensing, as demonstrated with dynorphin and interferon-γ, the opposite is also true since 
bacterial communication molecules of the quorum sensing, apart from regulating the expression of 
virulence factors, can themselves modulate the host immunological system
 [102-104]. For instance, it 
appears that in Pseudomonas, bacterial signal molecules such as N-(3-oxododecanoyl)-l-homoserine 
lactone (3oxo-HSL) and Pseudomonas Quinolone Signal (PQS) possess dual activities: inducers of 
virulence factors but also immune-modulators facilitating the infective properties of the   
pathogen [105]. 
2.3. Gram-negative Bacteria and Peptide Hormones 
The intense use of antibiotics has provoked the emergence of antibiotic-resistant strains of many 
Gram-negative bacterial species [106], requiring the development of new strategies to treat bacterial Sensors 2009, 9                  
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infections [107]. In this context, antimicrobial peptides appeared as a promising solution [108, 109]. 
Antimicrobial host defense peptides are widely produced by animals and plants and represent a very 
ancient defense mechanism [110]. Most of these peptides have cationic properties that allow 
interactions with the bacterial cytoplasmic membrane [111-113]. However, bacteria have developed 
mechanisms to resist antimicrobial peptides [114,115]. These mechanisms have been extensively 
studied in Salmonella typhimurium but are also present in other bacterial pathogens including Shigella 
flexneri, Erwinia chrysantemi or Escherichia coli [116-118]. For exemple, the PhoP/PhoQ system 
responds to sublethal concentrations of antimicrobial peptides to promote the resistance of   
bacteria [113]. It was demonstrated that the enzymatic activity of PhoQ, the sensor kinase of the 
system, is directly activated by antimicrobial peptides, indicating that sensor kinase present in the 
cytoplasmic membrane of bacteria may be essential to protecting micro-organisms such as S. 
typhimurium [113] or in P. aeruginosa [119,120] from the action of antimicrobial peptides. These 
observations reveal that bacteria can sense small natural eukaryotic peptides and initiate a 
transcriptional program that promotes bacterial virulence [113]. To identify natural peptides able to 
counteract bacterial infection, a series of neuropeptides and peptide hormones were identified which 
show structural homology with antibacterial peptides (Table 3) suggesting a secondary bactericidal 
activity for these communication molecules [43,121-126]. 
A significant percentage of patients who develop melioidosis have preexisting diabetes mellitus, a 
hypothesis was presented that insulin may modulate the physiology of Burkholderia pseudomallei. 
Further demonstrations led to show that insulin markedly inhibits the growth of B. pseudomallei [42]. 
Binding studies revealed that B. pseudomallei express a specific and saturable insulin binding site 
allowing the simultaneous recognition of 5,000 insulin molecules per bacterial surface [42]. This 
property of B. pseudomallei could explain the influence of serum insulin levels on the pathogenic 
activity of the bacterium during septicemic infections [42]. It was also suggested that, as in eukaryotes, 
the insulin receptor expressed by B. pseudomallei may be associated to a signal coupling system 
involving phospholipase and protein tyrosine phosphatase [127]. These results have been questioned 
since contradictory studies have indicated that the inhibition of insulin on B. pseudomallei should be 
ascribed to the presence of m-cresol, a preservative, in the preparation [128]. The explanation of the 
sensitivity of diabetics to melioidosis remains controversial [129] and further investigations are 
necessary to confirm the expression of a high-affinity binding site for human insulin on   
B. pseudomallei. 
The natural ecological niche of Helicobacter pylori is the gastric mucosa, an environment normally 
hostile to the majority of microorganisms. In the stomach, this human pathogen is in contact with food 
but also with different hormones involved in gastric regulation such as gastrin and somatostatin. The 
fact that human gastrin levels are elevated during infection with H. pylori and return to basal levels 
after eradication of the bacterium confirms that H. pylori is normally exposed to this human hormone. 
This interaction should participate in the pathological activity of the bacterium since in vitro it has 
been demonstrated that human gastrin is able to stimulate the growth of H. pylori in a specific and 
dose-dependent manner by shortening the lag time, increasing the growth rate during the logarithmic 
phase, and rising the final bacterial concentration during the stationary phase [130,131]. These effects 
were observed over a wide range of concentrations, compatible with the physiological luminal and 
serum levels of gastrin. The interaction between H. pylori and gastrin was confirmed using 
125I-labeled Sensors 2009, 9                  
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gastrin and measuring bacterial uptake [131]. Although, it was also shown that cholecystokinin and 
pentagastrin specifically inhibit the binding of human gastrin on H. pylori [131] and only the human 
sequence of gastrin can stimulate the growth of bacteria [130]. The suspected H. pylori gastrin sensor 
has not yet been identified.  
 
Table 3. Peptide hormones and bacteria. 
Signal molecules  Bacterial species  Observed effect References 
Substance P 
Escherichia coli  Antibacterial [125] 
Pseudomonas aeruginosa  Antibacterial [158] 
Insulin  Burkholderia pseudomalei  ↓Growth [42] 
CGRP  Escherichia coli  Antibacterial [126] 
Chromogranins  Escherichia coli  Antibacterial [122] 
Somatostatin  Helicobacter pylori  ↓Growth [43] 
 
hBNP 
Pseudomonas aeruginosa 
Pseudomonas fluorescens 
E. coli; P. aeruginosa 
↑Virulence 
↑Virulence 
Antibacterial 
[44] 
[141] 
[135] 
CNP 
Pseudomonas fluorescens  ↑Virulence [141] 
Pseudomonas aeruginosa  ↑Virulence [44] 
Gastrin  Helicobacter pylori  ↑Growth [131] 
ACTH  Vibrio splendidus  ↑Growth [155] 
Neuropeptide Y  Escherichia coli  Antibacterial [125] 
This Table summarizes the different peptide hormones that were shown to modify directly Gram-
negative bacteria physiology, the peptide hormone-responsive bacteria and the observed effects. 
hBNP: human brain natriuretic peptide, CNP: c-type natriuretic peptide, CGRP: Calcitonin gene 
related peptide, ACTH: Adrenocorticotropic. 
 
Somatostatin is a polypeptide hormone which also regulates gastric function and cell proliferation [132]. 
In contrast to the above described effect of gastrin, at the concentration present in the human gastric 
liquid (10
-11 mol/L), somatostatin significantly inhibits the proliferation of H. pylori [43]. In eukaryotic 
cells, somatostatin acts through receptors coupled to cyclases activation via membrane associated G 
proteins [133]. It is interesting to note that, in H. pylori, somatostatin increases about 10 times the 
intra-bacterial concentration of cyclic Guanylate Mono-Phosphate (cGMP) and cyclic Adenosine 
Mono-Phosphate (cAMP), and that the antiproliferative effect of somatostatin is fully reproduced by 
use of a stable analogue of cGMP, 8-bromo-cGMP (8BrcGMP) [43]. Scatchard plot showed that H. pylori 
express one class of binding site for somatostatin with relatively high affinity (Kd, 0.31 nmol/L) [43]. A 
partial pharmacological characterization of this bacterial receptor revealed that the effect of 
somatostatin is only mimicked by somatostatin receptor sub-type 2 (SSRT-2) analogs and partially 
blocked by SSRT-2 antibodies [43]. The presence of a bacterial somatostatin sensor showing 
similarities with the eukaryotic SSRT-2 was clearly suspected. The fact that somatostatin neither binds 
to E. coli nor affects its proliferation, indicates that the expression of this bacterial sensor is restricted 
to specific bacterial species and suggests that a horizontal transfer occurs between eukaryotic cells and 
H. pylori. Sensors 2009, 9                  
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Natriuretic peptides, a family diuretic and osmoregulatory peptides, which possess a structure 
similar to cationic antimicrobial peptides [134], have been proposed as antimicrobial active peptides to 
a large spectrum of micro-organisms [135]. More precisely, it was shown that the human Brain 
Natriuretic Peptide (BNP) is bactericidal at the concentration of 60 µM, whereas other tested peptides 
were devoid of effect [135]. The fact that C-type natriuretic peptide (CNP) is able to make pores in 
reconstructed membrane [136] has reinforced the hypothesis of a functional antibacterial activity 
associated with this peptide family. Nethertheless, both BNP and CNP are present in the plasma at 
concentrations clearly lower than the ones used to evaluate their potential antibacterial properties (10 
pM versus 60 µM) [137]. Furthermore, it was shown that BNP concentration is increased in human 
blood during septic shock [138,139], and that plasma N-terminal pro-brain natriuretic peptide   
(NT-proBNP) increases in a model of systemic exposition to E. coli endotoxin (or lipopolysaccharide, 
LPS) in healthy volunteers [140]. It is then certain that pathogen bacteria are exposed to natriuretic 
peptides in the plasma during infection. In order to determine the real impact of natriuretic peptides on 
bacterial physiology, in our laboratory we studied the effect of human BNP and CNP, at micromolar 
range, on a family of pathogens well known for their implication in septic, shock, namely 
Pseudomonas. It was first observed that both human BNP and CNP at micromolar concentration have 
no effect on Pseudomonas growth or cultivability [44,141]. In contrast, exposure of P. aeruginosa to 
BNP and CNP provokes an enhancement of the virulent activity of this pathogen [44]. By homology 
with eukaryotes, where natriuretic peptides act through receptors coupled to cyclases, it was observed 
that free permeable stable analogs of cyclic AMP (dibutyry cyclic AMP, dbcAMP) and cyclic GMP 
(8BrcGMP), mimic the pro-virulent effect of BNP and CNP on P. aeruginosa. This observation and 
the two fold increase of intra-bacterial concentrations of cAMP measured after exposure to CNP 
strongly suggests the presence of cyclic nucleotide-dependent natriuretic peptide sensor in 
Pseudomonas [44]. It is well known that in Pseudomonas the adenylate cyclase CyaB serves as a 
primary sensor for the assimilation of host-generated signals and that its activation enhances the global 
virulence of Pseudomonas [142-144]. The presence in bacteria of numerous genes coding for 
membrane adenylate and guanylate cyclases [145] and the involvement of cyclases in the regulation of 
virulence support the existence of a complex pathway based on cyclic nucleotides and control the 
infectious potential of bacteria. It is suggested that activation of membrane adenylate and/or guanylate 
cyclases in Pseudomonas could lead to the formation of cAMP or cGMP as second messengers 
regulating  Pseudomonas virulence. The intracellular cascade involved in this process remains 
essentially unidentified. However, it does appear that the protein Vfr, a central cAMP-binding protein, 
that controls the production of numerous virulence factors in P. aeruginosa is also required for the 
action of natriuretic peptides, suggesting that the sensor for these peptides in Pseudomonas is 
functionally associated to Vfr [44]. The molecular form and the localization of the natriuretic peptide 
sensors in Pseudomonas require further investigations. In eukaryotic cells natriuretic peptide receptors 
exist under three principal subtypes which are all located in the cytoplasmic membrane. The studies 
realized in Pseudomonas suggest that different forms of natriuretic peptides sensors also exist in 
bacteria. Indeed, in P. aeruginosa natriuretic peptides act preferentially through cAMP [44] whereas in 
P. fluorescens these peptides essentially stimulate the production of cGMP [141]. We can not exclude 
an action of natriuretic peptides on cytoplasmic cyclases which are also present in prokaryotes [146] 
since analysis of the structure of CNP and BNP suggest that they could directly cross the cytoplasmic Sensors 2009, 9                  
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membrane. In contrast with dynorphin [100], such phenomenon have never been reported in eukaryote 
or prokaryote for natriuretic peptides.  
 
Table 4. Bacterial sensors for eukaryotic signal molecules. 
Signal molecules 
Putative 
sensors 
Binding Site 
affinity 
Bacterial 
species 
References 
IL-1β Caf1A  Kd=0.14  nM  Yersinia pestis  [93] 
TNF-α -  Kd=2.5  nM  Shigella flexneri  [91] 
Epinephrine 
/Norepinephrine 
QseC   Escherichia coli  [33] 
Epinephrine QseE/QseF    Escherichia coli  [64,65] 
Somatostatin SSRT2-like Kd=0.3  nM  Helicobacter pylori  [43] 
INF-γ OprF    Pseudomonas 
aeruginosa 
[96] 
Dynorphin Mvfr    Pseudomonas 
aeruginosa 
[99] 
GABA GBP  Kd=65  nM  Pseudomonas 
fluorescens 
[82] 
This Table lists the putative Gram-negative bacteria sensors for eukaryotic signal molecules 
identified until now, their binding affinity and the species where they were found. GABA: gamma 
aminobutyric acid. 
 
Sensors showing high homology with eukaryotic receptors have been identified in bacteria, even 
though the exact nature of the ligand still remains uncertain both in eukaryotes and prokaryotes. This is 
the case of the Translocator Protein (TSPO), previously identified as peripheral-type benzodiazepine 
receptor, that was initially described in the outer-membrane of mitochondria [147] but was also found 
in the bacterium Rhodobacter sphaeroides [148] and related micro-organisms of the α-subdivision of 
purple bacteria [149]. As theses organisms likely gave rise to the endosymbiont at the origin of 
mitochondria, the existence of TSPO in these bacteria was originally considered to be a relic of 
evolution. However, recent studies indicate that TSPO is widely distributed in prokaryotes, although 
its presence is irregular even into a same genus [150]. These variations have been ascribed to the 
presence of an abundance of genes coding transposases at the vicinity of tspO, suggesting important 
but ancient exchanges between bacteria, and may be eukaryotes. In Rhodobacter TSPO serves as an 
oxygen sensor [151], whereas its functions in Gram-negative bacteria such as P. fluorescens, is 
apparently more complex including regulation of adhesion and virulence [150]. Worth mentioning, in 
Pseudomonas, as in mitochondria, TSPO is functionally associated to a membrane porin, although its 
localization in the membrane and sense of insertion should be notably different [150]. 
3. Conclusions and Perspectives 
It appears nowadays that eukaryotic signal molecules have multiple and fundamental effects on 
bacterial physiology and more particularly on pathogens. The distribution of bacterial sensors appears 
heterogeneous since they are present in all compartments of Gram-negative bacteria (Figure 1).  Sensors 2009, 9                  
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Figure 1. Location of the characterized bacterial sensors for eukaryotic signal molecules.  
 
The Gram-negative cell envelope is composed of the periplasmic space confined between the outer 
membrane and the inner membrane. The cell envelop separates the extracellular domain which 
contains eukaryotic ligands (top of the figure) and the cytoplasmic domain of the bacteria. The 
name of the putative sensors and the references associated to their characterization are indicated on 
the bottom of the figure. GABA: gamma aminobutyric acid. 
 
However, the whole number of bacterial sensors completely characterized at a molecular level 
remains limited (Table 4). A reason for this situation should be the difficulty in characterizing bacterial 
sensors for eukaryotic molecules, especially in the case of neurotransmitters. The identification of a 
putative receptor-mediated process in bacteria generally starts from clinical or environmental 
observations where it is difficult to distinguish the role of the prokaryotic and eukaryotic cellular 
partners. For that reason, the involvement of bacteria in many apparently non-infectious pathologies, 
including atherosclerosis, Parkinson disease or biliary cirrhosis, remains controversial. The “dogma” 
of the real sterility of the inner medium in metazoans, including humans, is now even brought forward. 
A major limitation to the identification of bacteria sensors to eukaryotic messengers is our very limited 
knowledge of their pharmacology and consequently the quasi absence of chemical tools (specific 
agonists or antagonists) designed for their study. In parallel, a molecular approach using eukaryotic 
receptor sequences in order to “fish” for putative bacterial sensors for hormones or neurotransmitters 
remains speculative in regard to the divergence of these two kingdoms [26,31].The present review 
shows the richness and diversity of host-pathogen interactions, and their consequences for human 
health. Treatments such as, gastric acid suppression, vasoactive agents and opioids among others 
certainly limit the ability of the intestinal tract to excrete non-commensal pathogens, and artificial Sensors 2009, 9                  
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nutrition can favor the exposure of pathogens like P. aeruginosa to a composite environmental cue that 
can directly activate its virulence circuitry [96,99,152,153]. In this regard, understanding of the 
mechanisms by which Pseudomonas or other pathogens activate the expression of their virulent profile 
in response to the stressed host, must be an important tool to anticipate the consequences of these 
virulence modulations on the normal and pathologic human microbiome. Identification of the sensors 
involved in these processes is opening a new wide field of promising research. Near the 
characterization of the binding domains of these bacterial types of sensors, decipher the signal 
transduction network associated to their activation represent also an important challenge in order to 
develop therapies to counteract the propagation of pathogen in host.  
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